Premature babies diagnosed with bronchopulmonary dysplasia (BPD) face the risk of rehospitalization, delayed brain development, and respiratory problems throughout childhood. No FDA-approved therapies are available for BPD—which is why the new FDA designation for AyuVis's drug candidate, AVR-48, could lead to game-changing impact.
Dallas-based SB22, the first fully immersive betting and transactional platform that does not rely on any legacy technology, has brought on Keith Wall as a strategic advisor to support its continued expansion....
Dallas-based enterprise browser unicorn Island has added Keith Weatherford to its executive team as vice president of worldwide channel sales.
Island emerged from stealth in February 2022. Valued at $1.3 billion in March, the startup continues to attract big investments for its enterprise browser, which aims to protect companies’ SaaS tools and internal web apps from data leaks with a long list of security features....